
Tuesday, October 25, 2011
Colorado Murders Argued To Be Caused By Chantix

Friday, October 21, 2011
Cases Build for Chantix Suicides and Suicide Attempts, FDA Ups Warning

Thursday, October 13, 2011
Heart Attacks Just Now Understood As Chantix Side Effect
Last month, the FDA did take some action on risks associated with Chantix cardiovascular problems by warning
that people with pre-existing heart problems could face a higher risk of
cardiovascular events if they take the drug. The information, which was added
to the “Warnings and Precautions” section of the Chantix label, was based on a
study that assessed Chantix for smoking cessation in 700 patients aged 35 to 75
years with stable, documented cardiovascular disease. Chantix was approved in the United States by the FDA in 2006 as a
prescription medication to help people quit smoking. The drug works by reducing
the positive feelings that come from cigarettes, blocking the receptors in the
brain commonly stimulated by nicotine. However, the impact of the drug on the
brain has resulted in a number of reports from users who experienced sudden,
unusually aggressive behavior, thoughts of self-harm and extreme cases, Chantix suicide.
Wednesday, October 12, 2011
Chantix Suicide Most Critical Side Effect of Quit Smoking Drug
In
2008 The FDA announced a public health advisory about
abnormal behavior, agitation, Chantix depression, suicidal ideation, and actual
suicidal behavior with Pfizer’s anti-smoking drug. The FDA provided updated
numbers - 491 cases of suicidal thinking or behavior, including 420 in the US
and of those, there were 39 suicides, including 34 in the US. Many of the cases were reported for patients
without any prior history of psychiatric illness. Government scientists
are conducting further investigating into the drug and, specifically, the
reports of Chantix suicide and suicidal ideation. Chantix, approved in 2006, works
by blocking nicotine receptors to the brain. Chantix is the first such nicotine
receptor partial agonist approved by the FDA. It was heralded as an alternative
to other smoking cessation drugs and nicotine replacement therapy.
Tuesday, October 11, 2011
Chantix Heart Attack Evidence Mounting
Many users of the popular smoking cessation drug are familiar with the adverse Chantix side effects that have been linked to the drug, including psychological conditions
and cardiovascular problems. These risks include suicidal thoughts, suicide,
increased rage or aggression, depression, and mood swings as well as Chantix heart attack, vascular disease, angina pectoris, and coronary revascularization.
These problems, particularly the ones related to heart problems, can also
manifest in smokers because of the smoking itself, making filing lawsuits
regarding Chantix heart problems a little more tricky than they might otherwise
be.
Wednesday, October 5, 2011
Chantix Multidistrict Litigation Inching Forward

Most
Chantix cases involved in multidistrict litigation are related to Chantix suicide and suicide attempts, which is one of the more common psychological
side effects of the popular smoking cessation aid. However, there are a
multitude of other Chantix side effects listed as
Tuesday, October 4, 2011
Chantix Lawsuit Settlements Gauged by Bellwether Trials

Chantix
psychological problems are a highly-publicized phenomenon which seems to
develop mostly in patients with a personal or family history of psychological
disorders or behavioral and emotional problems. These same people were
deliberately left out of Chantix clinical trials by drugmaker Pfizer, despite
the fact that statistically, people with psychological problems are much more
likely to be smokers than people without these conditions. Suicidal thoughts and
suicide attempts are not uncommon Chantix side effects, and some
Subscribe to:
Posts (Atom)